Tianxin Pharmaceutical (603235): Performance slightly exceeded expectations, optimistic that the product boom will continue
Tianxin Pharmaceutical (603235): B-vitamin prices rebounded, 1Q24's profit improved year over year, optimistic about the company's product planning and long-term development
Tianxin Pharmaceutical (603235): VB1 and VB6 price increases company performance as scheduled
Tianxin Pharmaceutical (603235): Prices are gradually picking up, and profit growth is expected to gradually resume
Tianxin Pharmaceutical (603235): Major products are booming, and profitability has increased significantly in Q4
Tianxin Pharmaceutical (603235): Sales volume pressure, revenue decline, optimistic about price recovery and future growth
Tianxin Pharmaceutical (603235): The diversified layout of vitamin B6 leaders is expected to open up room for growth
Tianxin Pharmaceutical (603235): Performance exceeded expectations, profitability increased markedly month-on-month
Tianxin Pharmaceutical (603235): Ready for winter and spring
No Data
No Data